Author:
Raymond Eric,Hobday Timothy,Castellano Daniel,Reidy-Lagunes Diane,García-Carbonero Rocío,Carrato Alfredo
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Modlin, I. M., Pavel, M., Kidd, M., et al. (2010). Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Alimentary Pharmacology & Therapeutics, 31(2), 169–188.
2. Rinke, A., Muller, H. H., Schade-Brittinger, C., et al. (2009). Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. Journal of Clinical Oncology, 27(28), 4656–4663.
3. Eriksson, B. (2010). New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? Current Opinion in Oncology, 22(4), 381–386.
4. Hansel, D. E., Rahman, A., Hermans, J., et al. (2003). Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression. Modern Pathology, 16(7), 652–659.
5. Fjällskog, M. L., Hessman, O., Eriksson, B., et al. (2007). Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas. Acta Oncológica, 46(6), 741–746.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献